跳至主要内容
临床试验/IRCT20210209050313N1
IRCT20210209050313N1尚未招募3 期

Comparison of triple treatment regimen containing levofloxacin with triple treatment regimen containing clarithromycin in the first line of treatment of patients with Helicobacter pylori infection referred to the clinic of Imam Khomeini Hospital during 2021-2022.

Tehran University of Medical Sciences0 个研究点目标入组 130 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Confirmation of the presence of H.pylori by fecal antigen test

排除标准

  • History of previous treatment for eradication of Helicobacter pylori
  • Age less than 18 years and over 65 years
  • History of allergy or severe reaction to drugs used in the plan
  • History of major surgery on the gastrointestinal tract such as bilirut and bypass and gastrogenostomy And gastrectomy
  • Severe underlying disease such as liver failure) Cirrhosis of the liver (or kidney) Creatinine above 2 (or proven malignancy Untreated active
  • Active pregnancy or lactation
  • Inability to follow up
  • Use of proton pump inhibitors And antibiotics in the last 4 weeks
  • Contraindications to the use of prescription drugs

研究者

相似试验